65.49 USD
+0.24 (+0.37%)
65.65 USD
+0.16 (+0.24%)
Taking everything into account, DXCM scores 7 out of 10 in our fundamental rating. DXCM was compared to 188 industry peers in the Health Care Equipment & Supplies industry. DXCM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make DXCM suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year DXCM was profitable.
In the past year DXCM had a positive cash flow from operations.
DXCM had positive earnings in each of the past 5 years.
Each year in the past 5 years DXCM had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.61%, DXCM belongs to the top of the industry, outperforming 92.02% of the companies in the same industry.
Looking at the Return On Equity, with a value of 26.44%, DXCM belongs to the top of the industry, outperforming 96.81% of the companies in the same industry.
With an excellent Return On Invested Capital value of 15.72%, DXCM belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DXCM is above the industry average of 8.78%.
The last Return On Invested Capital (15.72%) for DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
DXCM has a Profit Margin of 15.96%. This is amongst the best in the industry. DXCM outperforms 92.02% of its industry peers.
In the last couple of years the Profit Margin of DXCM has grown nicely.
Looking at the Operating Margin, with a value of 18.41%, DXCM belongs to the top of the industry, outperforming 90.43% of the companies in the same industry.
In the last couple of years the Operating Margin of DXCM has grown nicely.
DXCM's Gross Margin of 60.20% is in line compared to the rest of the industry. DXCM outperforms 59.04% of its industry peers.
DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DXCM is creating value.
The number of shares outstanding for DXCM has been increased compared to 1 year ago.
Compared to 5 years ago, DXCM has more shares outstanding
The debt/assets ratio for DXCM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.87 indicates that DXCM is not in any danger for bankruptcy at the moment.
DXCM has a Altman-Z score of 4.87. This is in the better half of the industry: DXCM outperforms 77.13% of its industry peers.
The Debt to FCF ratio of DXCM is 2.36, which is a good value as it means it would take DXCM, 2.36 years of fcf income to pay off all of its debts.
DXCM has a better Debt to FCF ratio (2.36) than 86.70% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, DXCM is in line with its industry, outperforming 44.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 4.87 |
ROIC/WACC1.96
WACC8%
2.3 Liquidity
A Current Ratio of 1.56 indicates that DXCM should not have too much problems paying its short term obligations.
DXCM has a Current ratio of 1.56. This is in the lower half of the industry: DXCM underperforms 72.34% of its industry peers.
A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.38, DXCM is doing worse than 60.64% of the companies in the same industry.
DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.41% over the past year.
The Earnings Per Share has been growing by 29.25% on average over the past years. This is a very strong growth
DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
Based on estimates for the next years, DXCM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.19% on average per year.
DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.47% yearly.
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.19%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.47%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.21, which means the current valuation is very expensive for DXCM.
DXCM's Price/Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 71.28% of the companies in the same industry.
DXCM is valuated rather expensively when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.80 indicates a quite expensive valuation of DXCM.
Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than the industry average as 73.40% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, DXCM is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.21 | ||
| Fwd PE | 25.8 |
4.2 Price Multiples
DXCM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DXCM is valued cheaply inside the industry as 85.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.05 | ||
| EV/EBITDA | 21.52 |
4.3 Compensation for Growth
DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DXCM may justify a higher PE ratio.
DXCM's earnings are expected to grow with 22.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)1.2
EPS Next 2Y24.04%
EPS Next 3Y22.49%
5. Dividend
5.1 Amount
DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
65.49
+0.24 (+0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner Change20.08%
Ins Owners0.19%
Ins Owner Change0.48%
Market Cap25.54B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85
Price Target88.3 (34.83%)
Short Float %3.45%
Short Ratio2.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-15.5%
PT rev (3m)-16.28%
EPS NQ rev (1m)-4.28%
EPS NQ rev (3m)-4.66%
EPS NY rev (1m)0.62%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)-1.09%
Revenue NQ rev (3m)-1.25%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.21 | ||
| Fwd PE | 25.8 | ||
| P/S | 5.66 | ||
| P/FCF | 24.05 | ||
| P/OCF | 17.64 | ||
| P/B | 9.37 | ||
| P/tB | 9.74 | ||
| EV/EBITDA | 21.52 |
EPS(TTM)1.86
EY2.84%
EPS(NY)2.54
Fwd EY3.88%
FCF(TTM)2.72
FCFY4.16%
OCF(TTM)3.71
OCFY5.67%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.28
PEG (5Y)1.2
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 4.87 |
F-Score5
WACC8%
ROIC/WACC1.96
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.19%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.47%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.12%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
What is the valuation status for DXCM stock?
ChartMill assigns a valuation rating of 6 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DEXCOM INC (DXCM) stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 35.21 and the Price/Book (PB) ratio is 9.37.